Cargando…
Ovalbumin-induced plasma interleukin-4 levels are reduced in ceramide kinase-deficient DO11.10 RAG1(-/- )mice
Ceramide kinase (CERK) produces the bioactive lipid ceramide-1-phosphate (C1P) and is a key regulator of ceramide and dihydroceramide levels. It is likely that CERK and C1P play a role in inflammatory processes but the cells involved and the mechanisms used remain to be clarified. In particular, the...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2817648/ https://www.ncbi.nlm.nih.gov/pubmed/20053284 http://dx.doi.org/10.1186/1476-511X-9-1 |
_version_ | 1782177219690364928 |
---|---|
author | Niwa, Satoru Urtz, Nicole Baumruker, Thomas Billich, Andreas Bornancin, Frédéric |
author_facet | Niwa, Satoru Urtz, Nicole Baumruker, Thomas Billich, Andreas Bornancin, Frédéric |
author_sort | Niwa, Satoru |
collection | PubMed |
description | Ceramide kinase (CERK) produces the bioactive lipid ceramide-1-phosphate (C1P) and is a key regulator of ceramide and dihydroceramide levels. It is likely that CERK and C1P play a role in inflammatory processes but the cells involved and the mechanisms used remain to be clarified. In particular, the impact of CERK on T-cell biology has not been studied so far. Here, we used Cerk(-/- )mice backcrossed with DO11.10/RAG1(-/- )mice to probe the effect of CERK ablation on T-cell activation. Levels of interleukin (IL)-2, IL-4, IL-5, IL-13, of tumor necrosis factor (TNF)-α, and of interferon (INF)-γ were recorded following ovalbumin challenge in vivo and using ovalbumin-treated splenocytes ex- vivo. Absence of CERK led to a significant decrease in the production of IL-4, thus suggesting that CERK may polarize T cells towards the T(H)2 cell subtype. However, the importance of CERK to T(H)2 cell biology will have to be investigated further because in a model of asthma, which is T(H)2-cell driven, Cerk(-/- )mice responded like wild-type animals. |
format | Text |
id | pubmed-2817648 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-28176482010-02-09 Ovalbumin-induced plasma interleukin-4 levels are reduced in ceramide kinase-deficient DO11.10 RAG1(-/- )mice Niwa, Satoru Urtz, Nicole Baumruker, Thomas Billich, Andreas Bornancin, Frédéric Lipids Health Dis Research Ceramide kinase (CERK) produces the bioactive lipid ceramide-1-phosphate (C1P) and is a key regulator of ceramide and dihydroceramide levels. It is likely that CERK and C1P play a role in inflammatory processes but the cells involved and the mechanisms used remain to be clarified. In particular, the impact of CERK on T-cell biology has not been studied so far. Here, we used Cerk(-/- )mice backcrossed with DO11.10/RAG1(-/- )mice to probe the effect of CERK ablation on T-cell activation. Levels of interleukin (IL)-2, IL-4, IL-5, IL-13, of tumor necrosis factor (TNF)-α, and of interferon (INF)-γ were recorded following ovalbumin challenge in vivo and using ovalbumin-treated splenocytes ex- vivo. Absence of CERK led to a significant decrease in the production of IL-4, thus suggesting that CERK may polarize T cells towards the T(H)2 cell subtype. However, the importance of CERK to T(H)2 cell biology will have to be investigated further because in a model of asthma, which is T(H)2-cell driven, Cerk(-/- )mice responded like wild-type animals. BioMed Central 2010-01-06 /pmc/articles/PMC2817648/ /pubmed/20053284 http://dx.doi.org/10.1186/1476-511X-9-1 Text en Copyright ©2010 Niwa et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Niwa, Satoru Urtz, Nicole Baumruker, Thomas Billich, Andreas Bornancin, Frédéric Ovalbumin-induced plasma interleukin-4 levels are reduced in ceramide kinase-deficient DO11.10 RAG1(-/- )mice |
title | Ovalbumin-induced plasma interleukin-4 levels are reduced in ceramide kinase-deficient DO11.10 RAG1(-/- )mice |
title_full | Ovalbumin-induced plasma interleukin-4 levels are reduced in ceramide kinase-deficient DO11.10 RAG1(-/- )mice |
title_fullStr | Ovalbumin-induced plasma interleukin-4 levels are reduced in ceramide kinase-deficient DO11.10 RAG1(-/- )mice |
title_full_unstemmed | Ovalbumin-induced plasma interleukin-4 levels are reduced in ceramide kinase-deficient DO11.10 RAG1(-/- )mice |
title_short | Ovalbumin-induced plasma interleukin-4 levels are reduced in ceramide kinase-deficient DO11.10 RAG1(-/- )mice |
title_sort | ovalbumin-induced plasma interleukin-4 levels are reduced in ceramide kinase-deficient do11.10 rag1(-/- )mice |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2817648/ https://www.ncbi.nlm.nih.gov/pubmed/20053284 http://dx.doi.org/10.1186/1476-511X-9-1 |
work_keys_str_mv | AT niwasatoru ovalbumininducedplasmainterleukin4levelsarereducedinceramidekinasedeficientdo1110rag1mice AT urtznicole ovalbumininducedplasmainterleukin4levelsarereducedinceramidekinasedeficientdo1110rag1mice AT baumrukerthomas ovalbumininducedplasmainterleukin4levelsarereducedinceramidekinasedeficientdo1110rag1mice AT billichandreas ovalbumininducedplasmainterleukin4levelsarereducedinceramidekinasedeficientdo1110rag1mice AT bornancinfrederic ovalbumininducedplasmainterleukin4levelsarereducedinceramidekinasedeficientdo1110rag1mice |